BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16314341)

  • 1. Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency.
    Parsons BL; Delongchamp RR; Beland FA; Heflich RH
    Mutagenesis; 2006 Jan; 21(1):29-34. PubMed ID: 16314341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of 4-aminobiphenyl-induced somatic H-ras mutation in mouse liver DNA correlate with potential for liver tumor development.
    Parsons BL; Beland FA; Von Tungeln LS; Delongchamp RR; Fu PP; Heflich RH
    Mol Carcinog; 2005 Apr; 42(4):193-201. PubMed ID: 15761837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACB-PCR measurement of spontaneous and furan-induced H-ras codon 61 CAA to CTA and CAA to AAA mutation in B6C3F1 mouse liver.
    Banda M; Recio L; Parsons BL
    Environ Mol Mutagen; 2013 Oct; 54(8):659-67. PubMed ID: 24038307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.
    Qin X; Liu L; Gerson SL
    Oncogene; 1999 Jul; 18(30):4394-400. PubMed ID: 10439048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and types of spontaneous Hprt lymphocyte mutations in Pms2-deficient mice.
    Shaddock JG; Dobrovolsky VN; Mittelstaedt RA; Heflich RH; Parsons BL
    Mutat Res; 2006 Mar; 595(1-2):69-79. PubMed ID: 16336979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.
    Shao C; Yin M; Deng L; Stambrook PJ; Doetschman T; Tischfield JA
    Oncogene; 2002 Apr; 21(18):2840-5. PubMed ID: 11973643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pms2 deficiency results in increased mutation in the Hprt gene but not the Tk gene of Tk(+/-) transgenic mice.
    Dobrovolsky VN; McKinzie PB; Shaddock JG; Mittelstaedt RA; Heflich RH; Parsons BL
    Mutagenesis; 2003 Jul; 18(4):365-70. PubMed ID: 12840110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
    Shin CY; Mellon I; Turker MS
    Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
    Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
    Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
    Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
    Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
    Baross-Francis A; Makhani N; Liskay RM; Jirik FR
    Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl/10J mouse liver tumours.
    Lord PG; Hardaker KJ; Loughlin JM; Marsden AM; Orton TC
    Carcinogenesis; 1992 Aug; 13(8):1383-7. PubMed ID: 1499088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres.
    Siegl-Cachedenier I; Muñoz P; Flores JM; Klatt P; Blasco MA
    Genes Dev; 2007 Sep; 21(17):2234-47. PubMed ID: 17785530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
    Qin X; Zhou H; Liu L; Gerson SL
    Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for Pms2 in the prevention of tandem CC --> TT substitutions induced by ultraviolet radiation and oxidative stress.
    Shin-Darlak CY; Skinner AM; Turker MS
    DNA Repair (Amst); 2005 Jan; 4(1):51-7. PubMed ID: 15533837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression.
    Parsons BL; Culp SJ; Manjanatha MG; Heflich RH
    Carcinogenesis; 2002 Jun; 23(6):943-8. PubMed ID: 12082015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.
    Fedier A; Ruefenacht UB; Schwarz VA; Haller U; Fink D
    Br J Cancer; 2002 Oct; 87(9):1027-33. PubMed ID: 12434296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice.
    Manjanatha MG; Li EE; Fu PP; Heflich RH
    J Toxicol Environ Health; 1996 Feb; 47(2):195-208. PubMed ID: 8598575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.